Artes Biotechnology

Recombinant protein production, process and vaccine development from microbial expression systems

placeLangenfeld, North Rhine Westphalia, Germany calendar_todayFounded 2002 groups22 employees language artes-biotechnology.biz

Registered entities

Innovation

8 patent families (6 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 61 times.

YearFilings
20121
20131
20141
20161
20201
20211

Social engagement

Social engagement: 1.5K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%

Recent activity

31 Mar 2026
Product launch
ARTES R21 vaccine
26 Mar 2026
Partnership
Provenance Bio
Coming soon